Amis, Zameer .
HRN: 21-34-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
10/02/2022
10/09/2022
PO
1ml
BID
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes